(Q61820509)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031824%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Molecular and biochemical profiling of a heparin-derived oligosaccharide, C3 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031824%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031824%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

Bertalan Dudas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031824%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Asif Daud

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031824%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Omer Iqbal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031824%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Debra Hoppensteadt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031824%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Walter Jeske

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031824%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Umberto Cornelli

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031824%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

John Lee

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031824%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Stanley Lorens

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031824%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Ronald Mervis

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031824%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Israel Hanin

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031824%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Ishan Capila

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031824%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Jawed Fareed

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031824%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Robert Linhardt

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031824%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 February 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031824%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031824%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031824%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031824%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

303-309

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031824%20AND%20SRC:MED&resulttype=core&format=json

Heparin oligosaccharides that pass the blood-brain barrier inhibit beta-amyloid precursor protein secretion and heparin binding to beta-amyloid peptide.

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900413-3

7 January 2021

Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900413-3

7 January 2021

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900413-3

7 January 2021

Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900413-3

7 January 2021

Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Abeta(25-35)-induced abnormal tau protein immunoreactivity in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900413-3

7 January 2021

Glycosaminoglycan polysulfate (Ateroid) in old-age dementias: effects upon depressive symptomatology in geriatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900413-3

7 January 2021

Inhibition of allergic late airway responses by inhaled heparin-derived oligosaccharides.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900413-3

7 January 2021

Low molecular weight heparin(s).

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900413-3

7 January 2021

Structure of heparin and heparin fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900413-3

7 January 2021

Molecular profiling and weight determination of heparins and depolymerized heparins

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900413-3

7 January 2021

Purification and characterization of heparan sulphate proteoglycan from bovine brain

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900413-3

7 January 2021

Human pharmacokinetics of glycosaminoglycans using deuterium-labeled and unlabeled substances: evidence for oral absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900413-3

7 January 2021

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900413-3

7 January 2021

Mass spectrometric evidence for the enzymatic mechanism of the depolymerization of heparin-like glycosaminoglycans by heparinase II.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900413-3

7 January 2021

Biochemical and pharmacologic rationale for the development of a synthetic heparin pentasaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900413-3

7 January 2021

Preparation and characterization of deuterium-labeled glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900413-3

7 January 2021

A sensitive competitive binding assay for exogenous and endogenous heparins

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900413-3

7 January 2021

10.1016/S0049-3848(01)00413-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031824%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference